Please enable JavaScript to continue using this application.

Compare $INO vs $SPRB | Chartloom

Compare

$INO vs $SPRB

Inovio Pharmaceuticals Inc · Spruce Biosciences, Inc

INO

Inovio Pharmaceuticals Inc

SPRB

Spruce Biosciences, Inc

Compare $INO vs $SPRB

Comparing Inovio Pharmaceuticals Inc and Spruce Biosciences, Inc

INOInovio Pharmaceuticals Inc

SPRBSpruce Biosciences, Inc

INOInovio Pharmaceuticals Inc

Market cap

$95M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

2.48x

Rev growth (TTM)

-100.0%

YTD performance

-32.0%

52W performance

-55.1%

FCF yield

-85.4%

SPRBSpruce Biosciences, Inc

Market cap

$121M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-51.4%

52W performance

-72.5%

FCF yield

-35.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

INO

SPRB

Detailed metrics comparison

INO

Inovio Pharmaceuticals Inc

SPRB

Spruce Biosciences, Inc

Market Cap

INO$95M

SPRB$121M

Enterprise Value

INO$63M

SPRB$32M

Price

INO$1.15

SPRB$44.05

P/E Ratio

INON/A

SPRBN/A

P/S Ratio

INO423.69x

SPRB26.75x

EV/Sales

INO312.32x

SPRB8.59x

EV/EBITDA

INO0.00x

SPRB0.00x

P/B Ratio

INO27.44x

SPRB1.57x

P/FCF Ratio

INON/A

SPRBN/A

EV/FCF

INO-0.78x

SPRB-0.75x

PEG Ratio

INON/A

SPRBN/A

Forward P/E (NTM)

INON/A

SPRBN/A

Forward P/S (NTM)

INO2.48x

SPRBN/A

Revenue (TTM)

INO$0

SPRB$0

Revenue Growth (YoY)

INO-100.0%

SPRBN/A

Forward Rev Growth

INO7491.0%

SPRB-75.6%

Gross Margin (TTM)

INO58.9%

SPRB0.0%

Operating Margin (TTM)

INO0.0%

SPRB0.0%

EBITDA Margin (TTM)

INO0.0%

SPRB0.0%

Net Margin (TTM)

INO0.0%

SPRB0.0%

FCF Margin (TTM)

INON/A

SPRBN/A

Net Income (TTM)

INO$-67M

SPRB$-51M

FCF (TTM)

INO$-81M

SPRB$-43M

EPS (TTM)

INO-$0.83

SPRB-$21.14

ROE (TTM)

INO-19050.0%

SPRB-15540.0%

ROA (TTM)

INO-11105.0%

SPRB-10167.0%

ROIC (TTM)

INO-19050.0%

SPRB-14349.0%

Cash

INO$32M

SPRB$96M

Debt

INO$0

SPRB$7M

Net Cash/Debt

INO$32M

SPRB$89M

Current Ratio (TTM)

INO1.00x

SPRB9.23x

Quick Ratio (TTM)

INO0.92x

SPRB8.81x

Debt/Equity (TTM)

INO0.00x

SPRB0.08x

Debt/Assets (TTM)

INO0.0%

SPRB0.0%

Interest Coverage (TTM)

INON/A

SPRBN/A

Net Debt/EBITDA (TTM)

INO0.00x

SPRB0.00x

Beta

INO1.68

SPRB3.63

52W Performance

INO-55.1%

SPRB-72.5%

YTD Performance

INO-32.0%

SPRB-51.4%

% from 52W High

INO-57.7%

SPRB-77.9%

% from 52W Low

INO104.2%

SPRB9.2%

Asset Turnover (TTM)

INO0.00x

SPRB0.07x

FCF Yield (TTM)

INO-85.4%

SPRB-35.3%

Earnings Yield (TTM)

INO-71.3%

SPRB-42.4%

Dividend Yield (TTM)

INON/A

SPRBN/A

Rule of 40

INO-100.0

SPRB0.0

EV/GP/RG

INON/A

SPRBN/A

Ticker research

View INO research View SPRB research

Metric	INO Inovio Pharmaceuticals Inc	SPRB Spruce Biosciences, Inc
Market & Valuation
Market Cap	$95M	$121M
Enterprise Value	$63M	$32M
Price	$1.15	$44.05
P/E Ratio	N/A	N/A
P/S Ratio	423.69x	26.75x
EV/Sales	312.32x	8.59x
EV/EBITDA	0.00x	0.00x
P/B Ratio	27.44x	1.57x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.78x	-0.75x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	2.48x	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	-100.0%	N/A
Forward Rev Growth	7491.0%	-75.6%
Profitability
Gross Margin (TTM)	58.9%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-67M	$-51M
FCF (TTM)	$-81M	$-43M
EPS (TTM)	-$0.83	-$21.14
ROE (TTM)	-19050.0%	-15540.0%
ROA (TTM)	-11105.0%	-10167.0%
ROIC (TTM)	-19050.0%	-14349.0%
Financial Health
Cash	$32M	$96M
Debt	$0	$7M
Net Cash/Debt	$32M	$89M
Current Ratio (TTM)	1.00x	9.23x
Quick Ratio (TTM)	0.92x	8.81x
Debt/Equity (TTM)	0.00x	0.08x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.68	3.63
52W Performance	-55.1%	-72.5%
YTD Performance	-32.0%	-51.4%
% from 52W High	-57.7%	-77.9%
% from 52W Low	104.2%	9.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.07x
FCF Yield (TTM)	-85.4%	-35.3%
Earnings Yield (TTM)	-71.3%	-42.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View INO research	View SPRB research

Valuation

P/S Ratio

SPRB

26.75x

INO

423.69x

EV/FCF

INO

-0.78x

SPRB

-0.75x

Growth & revenue

Revenue Growth TTM

INO

-100.0%

Forward Revenue Growth

INO

7491.0%

SPRB

-75.6%

Profitability & performance

Gross Margin

INO

58.9%

SPRB

0.0%

ROE

SPRB

-15540.0%

INO

-19050.0%

FCF Yield %

SPRB

-35.3%

INO

-85.4%

52-Week Performance

INO

-55.1%

SPRB

-72.5%

Detailed metrics comparison

INO

Inovio Pharmaceuticals Inc

SPRB

Spruce Biosciences, Inc

Market Cap

INO$95M

SPRB$121M

Enterprise Value

INO$63M

SPRB$32M

Price

INO$1.15

SPRB$44.05

P/E Ratio

INON/A

SPRBN/A

P/S Ratio

INO423.69x

SPRB26.75x

EV/Sales

INO312.32x

SPRB8.59x

EV/EBITDA

INO0.00x

SPRB0.00x

P/B Ratio

INO27.44x

SPRB1.57x

P/FCF Ratio

INON/A

SPRBN/A

EV/FCF

INO-0.78x

SPRB-0.75x

PEG Ratio

INON/A

SPRBN/A

Forward P/E (NTM)

INON/A

SPRBN/A

Forward P/S (NTM)

INO2.48x

SPRBN/A

Revenue (TTM)

INO$0

SPRB$0

Revenue Growth (YoY)

INO-100.0%

SPRBN/A

Forward Rev Growth

INO7491.0%

SPRB-75.6%

Gross Margin (TTM)

INO58.9%

SPRB0.0%

Operating Margin (TTM)

INO0.0%

SPRB0.0%

EBITDA Margin (TTM)

INO0.0%

SPRB0.0%

Net Margin (TTM)

INO0.0%

SPRB0.0%

FCF Margin (TTM)

INON/A

SPRBN/A

Net Income (TTM)

INO$-67M

SPRB$-51M

FCF (TTM)

INO$-81M

SPRB$-43M

EPS (TTM)

INO-$0.83

SPRB-$21.14

ROE (TTM)

INO-19050.0%

SPRB-15540.0%

ROA (TTM)

INO-11105.0%

SPRB-10167.0%

ROIC (TTM)

INO-19050.0%

SPRB-14349.0%

Cash

INO$32M

SPRB$96M

Debt

INO$0

SPRB$7M

Net Cash/Debt

INO$32M

SPRB$89M

Current Ratio (TTM)

INO1.00x

SPRB9.23x

Quick Ratio (TTM)

INO0.92x

SPRB8.81x

Debt/Equity (TTM)

INO0.00x

SPRB0.08x

Debt/Assets (TTM)

INO0.0%

SPRB0.0%

Interest Coverage (TTM)

INON/A

SPRBN/A

Net Debt/EBITDA (TTM)

INO0.00x

SPRB0.00x

Beta

INO1.68

SPRB3.63

52W Performance

INO-55.1%

SPRB-72.5%

YTD Performance

INO-32.0%

SPRB-51.4%

% from 52W High

INO-57.7%

SPRB-77.9%

% from 52W Low

INO104.2%

SPRB9.2%

Asset Turnover (TTM)

INO0.00x

SPRB0.07x

FCF Yield (TTM)

INO-85.4%

SPRB-35.3%

Earnings Yield (TTM)

INO-71.3%

SPRB-42.4%

Dividend Yield (TTM)

INON/A

SPRBN/A

Rule of 40

INO-100.0

SPRB0.0

EV/GP/RG

INON/A

SPRBN/A

Ticker research

View INO research View SPRB research

Metric	INO Inovio Pharmaceuticals Inc	SPRB Spruce Biosciences, Inc
Market & Valuation
Market Cap	$95M	$121M
Enterprise Value	$63M	$32M
Price	$1.15	$44.05
P/E Ratio	N/A	N/A
P/S Ratio	423.69x	26.75x
EV/Sales	312.32x	8.59x
EV/EBITDA	0.00x	0.00x
P/B Ratio	27.44x	1.57x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.78x	-0.75x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	2.48x	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	-100.0%	N/A
Forward Rev Growth	7491.0%	-75.6%
Profitability
Gross Margin (TTM)	58.9%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-67M	$-51M
FCF (TTM)	$-81M	$-43M
EPS (TTM)	-$0.83	-$21.14
ROE (TTM)	-19050.0%	-15540.0%
ROA (TTM)	-11105.0%	-10167.0%
ROIC (TTM)	-19050.0%	-14349.0%
Financial Health
Cash	$32M	$96M
Debt	$0	$7M
Net Cash/Debt	$32M	$89M
Current Ratio (TTM)	1.00x	9.23x
Quick Ratio (TTM)	0.92x	8.81x
Debt/Equity (TTM)	0.00x	0.08x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.68	3.63
52W Performance	-55.1%	-72.5%
YTD Performance	-32.0%	-51.4%
% from 52W High	-57.7%	-77.9%
% from 52W Low	104.2%	9.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.07x
FCF Yield (TTM)	-85.4%	-35.3%
Earnings Yield (TTM)	-71.3%	-42.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View INO research	View SPRB research